<DOC>
	<DOCNO>NCT01475643</DOCNO>
	<brief_summary>The objective study compare efficacy safety treatment postoperative inflammation follow ocular surgery childhood cataract .</brief_summary>
	<brief_title>Loteprednol vs Prednisolone Treatment Intraocular Inflammation Following Cataract Surgery Children .</brief_title>
	<detailed_description>The objective study compare efficacy safety topical Loteprednol Etabonate ( LE ) , 0.5 % , Prednisolone Acetate 1 % , treatment postoperative inflammation follow ocular surgery childhood cataract .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Loteprednol Etabonate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Subject candidate routine , uncomplicated surgery childhood cataract Subjects severe/serious ocular condition , unstable medical condition , Investigator 's opinion , may preclude study treatment followup . Subjects glaucoma , ocular hypertension , receive intraocular pressure ( IOP ) lower therapy either eye systemically . Subjects history steroidinduced IOP elevation either eye . Subjects know hypersensitivity contraindication study drug ( ) component drug formulation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Pediatric cataract</keyword>
</DOC>